The incidence of HLA DRB1*0103 in ulcerative colitis patients in North-Eastern Poland

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1436-1438

  Puzanowska, Beata ^a   Prokopowicz, D ^a   Ziarko, S ^b   Radziwon, P ^b   Lapinski, T W ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Reg Centre for Transfusion Medicine   (Poland)

Author keywords

Allele DRB1*0103; HLA class II; Polish nation; Ulcerative colitis

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; MALE; MOLECULAR DYNAMICS; PHENOTYPE; POLAND; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MALE; POLAND; SEROEPIDEMIOLOGIC STUDIES;

EID: 0141763517     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Satsangi J, Jewell DP, Bell JL: The genetics of inflammatory bowel disease. Gut 1997; 40:572-574.
2. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ: HLA-DR and DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999; 45:395-401.
3. Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Takata H, Sekiguchi S: Association of the human leukocyte-DR2 antigens with Japanese ulcerative colitis. Gastroenterology 1982; 82:413-418.
4. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR: Distinct association of HLA class II genes with inflammatory bowel disease. Gastroentrology 1993; 104:741-748.
5. Hohjoh H, Terada N, Honda Y, Juji T, Tokunaga K: Negative association of the HLA DRB1*1502 haplotype with human narcolepsy. Immunogenetics 2001; 52:299-301.
6. Hill AV: Immunogenetics and genomics. Lancet 2001; 357:2037-2041.
7. Olerup O, Zetterquist H: DR "low-resolution" PCR-SSP typing - a correction and an up-date. Tissue Antigens 1993; 41:55-56. (Letter to the editor)
8. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39:225-235.
9. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, Blankenstein M: Incidence rate of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996; 39:690-697.
10. Timmer A, Goebell H: Incidence of ulcerative colitis, 1980-1995 - a prospective study in an urban population in Germany. Z Gastroenterol 1999; 37:1079-1084.
11. Lopez-Larrea C, Sujirachato K, Mehra NK, Chiewsilp P, Isarangkura D, Kanga U, Dominguez O, Coto E, Pena M, Setien F: HLA-B27 subtypes in Asian patients with ankylosing spondylitis: evidence for new association. Tissue Antigens 1995; 45:169-176.
12. de la Concha EG, Fernandez-Arquero M, Lopez-Nava G, Martin E, Allcock RJ, Conejero L, Paredez JG, Diaz-Rubio M: Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 2000; 119:1491-1495.
13. Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, Kostenese PJ, Meuwisse, SG, Pena AS: Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol 1999; 115:294-300.
14. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T: HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 1999; 53:350-358.
15. Futami S, Aoyama N, Honskao Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Okano H, Miyamoto M, Inaba H: HLA-DRB1*1502 allele, subtype of DR15 is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995; 40:814-818.
16. Uyar FA, Imeryuz N, Saruhan-Direskeneli G, Ceken H, Ozdogan O, Sahin S, Tozun N: The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur J Immunogenet 1998; 25:293-296.
17. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP: Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112:1845-1853.
18. Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L: Polymorphisms in tumor necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: Association with HLA-Dr and DQ alleles and subclinical markers. Scand J Gastroenterol 1999; 10:1025-1032.
19. Folwaczny C, Zahn R, Brunnler G, Albert E, Koenig A, Noehl N, Loeschke K, Fricke H: Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status on clinical characteristics in patients with ulcerative colitis. Z Gastroenterol 1999; 37:133-140.